VRTX three-lens brief
Evidence-based stock research on VRTX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 17.2pp over 30 days. · Debt-to-equity of 10.9 — balance-sheet-heavy.
- Underperforming SPY by 17.2pp over 30 days.
- Analyst mean target $548.45 — 27% above current (29 analysts).
- Debt-to-equity of 10.9 — balance-sheet-heavy.
VRTX closed at $430.29 (-1.11%) as of 2026-04-25. Market cap: $109.45B. P/E (trailing) 28.1. Positives: analyst mean target $548.45 — 27% above current (29 analysts).. Concerns: underperforming SPY by 17.2pp over 30 days.; debt-to-equity of 10.9 — balance-sheet-heavy.. Last quarter: Revenue $3.19B, net income $1.19B, free cash flow $2.57B.
Why three lenses on VRTX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine VRTXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/VRTX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath VRTX brief"></iframe>